These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9708342)

  • 21. (R)-(-)- and (S)-(+)-adenallene: synthesis, absolute configuration, enantioselectivity of antiretroviral effect, and enzymic deamination.
    Megati S; Goren Z; Silverton JV; Orlina J; Nishimura H; Shirasaki T; Mitsuya H; Zemlicka J
    J Med Chem; 1992 Oct; 35(22):4098-104. PubMed ID: 1304169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazolo[3,4-d]pyrimidine ribonucleosides related to 2-aminoadenosine and isoguanosine: synthesis, deamination and tautomerism.
    Seela F; Xu K
    Org Biomol Chem; 2007 Sep; 5(18):3034-45. PubMed ID: 17728871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinetic characterization of adenosine deaminase activity in zebrafish (Danio rerio) brain.
    Rosemberg DB; Rico EP; Senger MR; Dias RD; Bogo MR; Bonan CD; Souza DO
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Sep; 151(1):96-101. PubMed ID: 18582589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasting behavior of conformationally locked carbocyclic nucleosides of adenosine and cytidine as substrates for deaminases.
    Marquez VE; Schroeder GK; Ludek OR; Siddiqui MA; Ezzitouni A; Wolfenden R
    Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):614-32. PubMed ID: 20183605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
    Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
    Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of (+)-cyclaradine-5'-esters as prodrugs for (+)-cyclaradine in animals.
    Lim J; Schwartz J; Loebenberg D; Miller GH; Symchowicz S; Lin C
    Antimicrob Agents Chemother; 1987 Jul; 31(7):998-1001. PubMed ID: 3662479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the anomeric effect an important factor in the rate of adenosine deaminase catalyzed hydrolysis of purine nucleosides? A direct comparison of nucleoside analogues constructed on ribose and carbocyclic templates with equivalent heterocyclic bases selected to promote hydration.
    Hernandez S; Ford H; Marquez VE
    Bioorg Med Chem; 2002 Aug; 10(8):2723-30. PubMed ID: 12057661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A transition state in pieces: major contributions of entropic effects to ligand binding by adenosine deaminase.
    Kati WM; Acheson SA; Wolfenden R
    Biochemistry; 1992 Aug; 31(32):7356-66. PubMed ID: 1510925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
    Koudriakova T; Manouilov KK; Shanmuganathan K; Kotra LP; Boudinot FD; Cretton-Scott E; Sommadossi JP; Schinazi RF; Chu CK
    J Med Chem; 1996 Nov; 39(23):4676-81. PubMed ID: 8917656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantum chemical study of the enzymatic deamination of benzoadenine derivatives. A theoretical model of the interactions occurring between nucleosides and the active site of adenosine deaminase.
    Orozco M; Canela EI; Franco R
    Eur J Biochem; 1990 Feb; 188(1):155-63. PubMed ID: 2156693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of adenosine deaminase and adenylate deaminase on adenosine and 2', 3(')-isopropylidene adenosine: role of the protecting group at different pH values.
    Alessandrini L; Ciuffreda P; Pavlovic R; Santaniello E
    Nucleosides Nucleotides Nucleic Acids; 2008 Jan; 27(1):31-6. PubMed ID: 18188767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
    Smith SH; Shipman C; Drach JC
    Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
    Falcon MG; Jones BR
    J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzymatic interconversion of isomorphic fluorescent nucleosides: adenosine deaminase transforms an adenosine analogue into an inosine analogue.
    Sinkeldam RW; McCoy LS; Shin D; Tor Y
    Angew Chem Int Ed Engl; 2013 Dec; 52(52):14026-30. PubMed ID: 24288262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of adenosine deaminase in extracts of Asperigillus terricola.
    Abu-Shady MR; Elshafei AM; el-Beih FM; Mohamed LA
    Acta Microbiol Pol; 1994; 43(3-4):305-11. PubMed ID: 7740980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemistry and pharmacology of apiose. 7. Susceptibility of some branched-chain sugar nucleosides to enzymatic deamination.
    Tronchet JM; Tronchet J; Graf R
    J Med Chem; 1974 Oct; 17(10):1055-6. PubMed ID: 4472858
    [No Abstract]   [Full Text] [Related]  

  • 37. Cytotoxic activity of the adenine arabinoside analogs, 2'-azido- and 2'-amino-2'-deoxy-beta-D-arabinofuranosyladenine.
    Lee SH; Unger FM; Christian R; Sartorelli AC
    Biochem Pharmacol; 1979 Apr; 28(7):1267-9. PubMed ID: 444286
    [No Abstract]   [Full Text] [Related]  

  • 38. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma levels and urinary excretion of vidarabine after repeated dosing.
    Buchanan RA; Kinkel AW; Alford CA; Whitley RJ
    Clin Pharmacol Ther; 1980 May; 27(5):690-6. PubMed ID: 7371366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
    Borondy PE; Chang T; Maschewske E; Glazko AJ
    Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.